StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
002524.SZ$3.88-2.76%
Fair $3.88+0.0%

002524.SZ

Guangzheng Eye Hospital Group Co.,Ltd.

Industrials / Metal FabricationShenzhen

$3.88

-0.11 (-2.76%)

Fairly Valued+0.0%Fair Value $3.88Fund rank 22/100 · Data gapFallback financials|
SA 13/F
F-Score: 5/9
High DebtDeclining RevenueLow Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 26% · confianza 25%

FCF escenarios

weak_data · normalized FCF $43.3M · quality 29.7/100

Data gap 22/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 43/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

13/100

F

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 3unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. Debt-to-Equity ratio is 7.83, above the 2.0 threshold Revenue has declined for 2 consecutive years ROE is -20.4%, below the 5% threshold
Thesis & Journal · 002524.SZLocal privado en este navegador · Guangzheng Eye Hospital Group Co.,Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$2.0B

P/E

N/A

•

EV/EBITDA

20.8x

↑

ROE

-20.4%

↓

Gross Margin

36.3%

↑

Debt/Equity

7.83

↑
52-Week Range$4
$4$6

TradingView lightweight chart

002524.SZ price, volumen y niveles de valoración

Último $3.880Periodo -55.4%
Fair value: $3.880

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+4.9%

FCF CAGR

+4.6%

FCF margin

10.8%

FCF / Net income

-4.91x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $885.2M · net income $-19.5M · FCF $95.7M

2022-FY → 2025-FY

Gross margin

36.3%+11.3% pts

Operating margin

3.6%+15.3% pts

Net margin

-2.2%+8.0% pts

FCF margin

10.8%-0.1% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$885.2M$885.2M$892.8M$1.07B$767.4M
Net Income$-19.5M$-19.5M$-174.7M$9.3M$-78.2M
EBITDA$124.4M$124.4M$-27.0M$147.0M$60.8M
EPS-0.04-0.04-0.340.02-0.15
Gross Margin36.3%36.3%36.8%35.1%25.0%
Operating Margin3.6%3.6%-0.1%4.5%-11.7%
Net Margin-2.2%-2.2%-19.6%0.9%-10.2%
Balance Sheet
Debt/Equity7.837.837.243.102.97
Current Ratio0.330.33———
Cash Flow
Free Cash Flow$95.7M$95.7M$43.3M$15.5M$83.6M
Returns
ROE-20.4%-20.4%-155.0%3.3%-28.6%
Valuation
P/E———322.50—
EV/EBITDA20.8320.83—25.6575.31
P/B19.7419.7415.7710.5414.04
Growth & Yield
Revenue Growth-0.9%-0.9%-16.9%40.1%—
EPS Growth88.2%88.2%-1800.0%113.3%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -8.5%

Total return

-8.5%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.34 → -0.04

Residual

-8.5%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-8.5%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.